Risk factors predicting intractability in focal epilepsy in children under 3years of age: A cohort study

Irawan Mangunatmadja1, Sofyan Ismael1, Sudigdo Sastroasmoro1

  • 1Department of Child Health, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Insights

Changes in seizure type and EEG rhythm evolution can predict intractable focal epilepsy in young children. Early identification aids treatment guidance for pediatric epilepsy management.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Focal onset epilepsy in children has a higher risk of intractability compared to generalized onset epilepsy.
  • Identifying risk factors for intractable epilepsy is crucial for guiding treatment in pediatric focal epilepsy cases.
  • Both initial diagnostic factors and the evolution of clinical and electroencephalographic features can predict intractability.

Purpose of the Study:

  • To investigate the predictive role of clinical and electroencephalographic (EEG) feature evolution in the intractability of focal epilepsy in young children.
  • To identify key factors that may indicate the development of intractable epilepsy in children aged one month to three years.

Main Methods:

  • A prospective cohort study involving children aged one month to three years with newly diagnosed focal epilepsy.
  • Standardized initial treatment with carbamazepine, with potential addition of valproic acid or phenobarbitone based on response.
  • Regular follow-up assessments including clinical evaluation, neurological and developmental status, and electroencephalography (EEG) to track changes and predict intractability.

Main Results:

  • Out of 71 subjects, 29.6% exhibited intractable epilepsy by the study's end.
  • Age of onset and initial neurological status were not significantly associated with intractable epilepsy.
  • Evolution of seizure type (RR 56.45) and background EEG rhythm (RR 56.51) were highly significant predictors of intractable epilepsy (p < 0.001).

Conclusions:

  • Changes in seizure type and the evolution of background EEG rhythm are significant predictors of intractable epilepsy in infants and toddlers with focal epilepsy.
  • These evolving features can help clinicians anticipate and manage treatment resistance in pediatric focal epilepsy.
  • The findings underscore the importance of monitoring clinical and EEG progression for predicting epilepsy intractability in young children.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
469
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
793
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
540